Quantcast

Latest PDE5 inhibitors Stories

2011-08-08 18:05:00

SAN DIEGO, Aug. 8, 2011 /PRNewswire/ -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq: APRI) announced today that it will file for market authorization to sell its erectile dysfunction drug, Vitaros(®), in Latin America. The Company also stated that it has engaged the services of Quintiles Global Regulatory Affairs, a leading international regulatory consultancy, to prepare its regulatory filings for Vitaros(®) for marketing approval in the...

2011-07-24 00:02:03

Medical Specialists Online Pharmacy - Specialists in the expert treatment of Erectile Dysfunction - discuss the results of the research conducted on behalf of the Journal of Periodontology that looks at the relationship between oral health and erectile dysfunction. Bury, Manchester (PRWEB) July 23, 2011 Research conducted on behalf of the Journal of Periodontology suggests a link between periodontitus, a severe form of gum disease, and erectile dysfunction. The study involved 70 individuals...

2011-06-30 05:45:00

MOUNTAIN VIEW, Calif., June 30, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of avanafil, its investigational drug for the treatment of erectile dysfunction (ED). The NDA submission follows the successful completion of an extensive phase 3 program for avanafil, which included over 1,350 patients, where avanafil was shown to be well tolerated and effective...

2011-06-28 05:18:00

MEMPHIS, Tenn., June 28, 2011 /PRNewswire/ -- Xpressdelivery.com was launched with an understanding of the market lacking a pharmacy that would be truly committed to providing high level of service without charging too much money. This pharmacy was started as a place where it would be possible to buy Viagra online, as well as purchase some other highly demanded medications that can be very expensive to buy without a prescription. Because of the company's close cooperation with the largest...

2011-06-13 09:26:00

SEOUL, South Korea, June 13, 2011 /PRNewswire/ -- Dong-A PharmTech Co., Ltd. and Dr. Falk Pharma GmbH announced positive results from an initial safety and efficacy portal hypertension study in man using udenafil, its new long-active phosphodiesterase inhibitor. The data was presented by the principal investigator, Prof. Wolfgang Kreisel, Department of Gastroenterology, Hepatology, Endocrinology and Infectious Diseases, University of Freiburg, Freiburg, Germany. In a 1-week open-label,...

2011-05-25 05:00:00

MOUNTAIN VIEW, Calif., May 25, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced positive results from a phase 3, placebo-controlled clinical trial of the investigational drug avanafil for the treatment of erectile dysfunction (ED) in patients following a radical prostatectomy. The study (REVIVE-RP, TA-303) met all primary endpoints by demonstrating improvement from baseline in erectile function as measured by the Sexual Encounter Profile (both SEP2 and SEP3) and improvements...

9a48775c5afd4b6ab06a64957bd08e32
2011-05-19 11:00:00

Hundreds of cases of sudden hearing loss in men from around the world may be linked to use of Viagra and similar impotence drugs, The Telegraph is reporting. Physicians have begun to warn that the prescriptions could damage a man's hearing after reports have surfaced of auditory complaints from men. Forty-seven suspected cases of sensorineural hearing loss "“ a rapid loss of hearing in one or both ears "“ were linked to Viagra and related drugs Cialis and Levitra. Users in the...

2011-05-17 11:30:00

MOUNTAIN VIEW, Calif., May 17, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that positive results from a pivotal phase 3 open-label clinical trial evaluating long-term safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED) were presented at the 2011 Annual Meeting of the American Urological Association in Washington, D.C. Laurence Belkoff, DO, FACOS, Chairman of the Department of Specialty Surgeries and the Division of...

2011-05-13 05:45:00

MOUNTAIN VIEW, Calif., May 13, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that data on avanafil, its investigational drug candidate, will be featured in a late breaking oral presentation at the American Urological Association (AUA) 2011 Annual Meeting, being held May 14-19, 2011 in Washington, D.C. Following are details about the presentation: The oral presentation will be given at the Walter E. Washington Convention Center in Washington, D.C., on Tuesday, May 17,...

2011-05-04 10:00:00

SAN DIEGO, May 4, 2011 /PRNewswire/ -- Aires Pharmaceuticals, Inc. today announced the hiring of Ed Parsley, D.O. as Chief Medical Officer. Dr. Parsley will fill a key role on Aires' leadership team and will be responsible for all clinical development activities for Aironite(TM), the company's lead product for treatment of pulmonary arterial hypertension (PAH). Dr. Parsley joins Aires from Pfizer where he was the Clinical Lead for ongoing clinical trials for Revatio (Sildenafil), Pfizer's...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.